United States

Marina Biotech Inc (MRNA.PK)

MRNA.PK on OTC Markets Group

23 Mar 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Marina Biotech provides Q1 2016 financial reports
Tuesday, 17 May 2016 08:00am EDT 

Marina Biotech Inc : Marina biotech provides first quarter 2016 financial reports and business update .Q1 revenue $250,000.  Full Article

Marina Biotech Inc announces license agreement
Monday, 28 Sep 2015 08:30am EDT 

Marina Biotech Inc:Marina Biotech and Hongene Biotechnology announce license agreement.Have exclusive rights to develop, supply and commercialize certain oligonucleotide amidites using Marina's Conformationally Restricted Nucleotide (CRN) chemistry.In return, Marina will receive royalties from the sale of CRN-based reagents.Agreement will establish a ready supply of CRN amidites for Marina's therapeutic research and development efforts.  Full Article

Marina Biotech announces $1.1 mm convertible preferred stock financing
Thursday, 6 Aug 2015 08:30am EDT 

Marina Biotech Inc:Enters into a definitive agreement with existing investors, for the issuance of convertible preferred stock at a conversion price equivalent to $0.40 per share of common stock resulting in gross proceeds to the company of $1.1 million.The offering is expected to close on or about Aug. 7.  Full Article

More From Around the Web

BRIEF-Marina Biotech announces merger with IthenaPharma

* Marina Biotech announces merger with IthenaPharma Source text for Eikon: Further company coverage: